GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- University of Southern California
- Study ID
- NCT07279571
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Non-Interventional Study — OTHERNon-interventional study
Study Details
This study seeks to understand how endometrial cancer patients get medical information about cancer care and their satisfaction with those health-seeking methods. It also assesses patient interest in using an artificial intelligence educational resource.
Key Dates
- First listed
- Dec 12, 2025
- Start date
- Jun 12, 2026
- Status verified
- Jun 2026
- Primary completion
- Jun 9, 2027
- Completion
- Jun 9, 2028
Study Design
- Enrollment
- 48 participants (estimated)
Arms
- Arm: ObservationalPatients complete a survey on study.
Primary Outcome Measure
Patient Satisfaction Scores [ Time Frame: Up to 1 year ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Los Angeles General Medical Center | Los Angeles | California | 90033 | Xiaoyue M. Guo (PRINCIPAL_INVESTIGATOR) |
| USC / Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | Xiaoyue M. Guo (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
By condition
By specialty
Related Studies
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPHASE1/PHASE2 · Recruiting · Children's Oncology Group · Birmingham, Alabama
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationRecruiting · Guardant Health, Inc. · Birmingham, Alabama
- A Beta-only IL-2 ImmunoTherapY StudyPHASE1/PHASE2 · Recruiting · Medicenna Therapeutics, Inc. · San Diego, California
- FOG-001 in Locally Advanced or Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · Parabilis Medicines, Inc. · Phoenix, Arizona